Collins M T, Remaley A T, Csako G, Pucino F, Skarulis M C, Balow J E, Sarlis N J
National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
J Endocrinol Invest. 2000 Jun;23(6):383-92. doi: 10.1007/BF03343742.
Patients with primary thyroid failure on levothyroxine (LT4) replacement who develop nephrotic syndrome (NS) may rarely present with an increase in LT4 requirements. In this report, we describe a patient with thyroid failure following radioactive iodine ablation for Graves' disease who required an escalation of LT4 doses following the onset of NS. The case presented with disproportionately elevated TSH levels in the presence of normal (or slightly subnormal) thyroid hormone levels, thus, masquerading as a state of "inappropriate" TSH secretion. This pattern of extreme dysregulation in thyroid function indices due to urinary loss of thyroid hormones has not been previously described in NS, and, therefore, extends the spectrum of endocrine manifestations of NS.
接受左甲状腺素(LT4)替代治疗的原发性甲状腺功能减退患者若出现肾病综合征(NS),可能很少会表现出LT4需求量增加。在本报告中,我们描述了一名因格雷夫斯病接受放射性碘消融术后出现甲状腺功能减退的患者,该患者在肾病综合征发作后需要增加LT4剂量。该病例在甲状腺激素水平正常(或略低于正常)的情况下出现促甲状腺激素(TSH)水平不成比例地升高,因此,伪装成“不适当”TSH分泌状态。由于甲状腺激素经尿液丢失导致甲状腺功能指标出现这种极端失调的模式此前在肾病综合征中尚未有过描述,因此,扩展了肾病综合征的内分泌表现谱。